Moreover, a comparison between metastatic prostate cancer tissues obtained from bone (B-PC, n = 21) and primary prostate cancer tissues (P-PC, n = 60) showed increased SNHG3 expression in B-PC samples. This evidence concerns the gene SNHG3 and prostate carcinoma.